Выходит 4 номеров в год
ISSN Печать: 0893-9675
ISSN Онлайн: 2162-6448
Indexed in
Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes
Краткое описание
Triple negative breast cancers (TNBCs), which are defined as estrogen-receptor, progesterone-receptor, and HER2-receptor negative, account for 10–20% of breast cancers, and they are associated with early metastasis, chemotherapeutic resistance, and poor survival rates. One aspect of TNBC that complicates its prognosis and the development of new molecular therapeutic targets is its clinical and molecular heterogeneity. Herein we compare TNBC and basal cytokeratin–positive breast cancers. We examine the different TNBC molecular subtypes, based on gene expression profiling, which include basal-like, mesenchymal, and luminal androgen receptors, in the context of their biology and impact on TNBC prognosis. We explore the potential role of inducible nitric oxide synthase (iNOS) in TNBC tumor biology and treatment responses. iNOS has been shown to induce p53 mutation accumulation, basal-like gene signature enrichment, and transactivation of the epidermal growth factor receptor (EGFR) via S-nitrosylation, all of which are key components of TNBC biology. Moreover, iNOS predicts poor outcome in TNBC, and iNOS inhibitors show efficacy against TNBC when used in combination with chemotherapy. We discuss molecular targeted approaches, including EGFR, PARP, and VEGF inhibitors and immunotherapeutics, that are under consideration for the treatment of TNBC and what role, if any, iNOS may play in their success.
-
Hulin Julie-Ann, Tommasi Sara, Elliot David, Mangoni Arduino A., Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitro, Biomedicine & Pharmacotherapy, 111, 2019. Crossref
-
Harrer Dennis C., Dörrie Jan, Schaft Niels, CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities–Merits and Challenges, International Journal of Molecular Sciences, 20, 23, 2019. Crossref
-
Kovács Patrik, Csonka Tamás, Kovács Tünde, Sári Zsanett, Ujlaki Gyula, Sipos Adrien, Karányi Zsolt, Szeőcs Dóra, Hegedűs Csaba, Uray Karen, Jankó Laura, Kiss Máté, Kiss Borbála, Laoui Damya, Virág László, Méhes Gábor, Bai Péter, Mikó Edit, Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer, Cancers, 11, 9, 2019. Crossref
-
Ehrenfeld Pamela, Cordova Francisco, Duran Walter N., Sanchez Fabiola A., S-nitrosylation and its role in breast cancer angiogenesis and metastasis, Nitric Oxide, 87, 2019. Crossref
-
Qin Jiang-Jiang, Yan Li, Zhang Jia, Zhang Wei-Dong, STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review, Journal of Experimental & Clinical Cancer Research, 38, 1, 2019. Crossref
-
Rigiracciolo Damiano Cosimo, Nohata Nijiro, Lappano Rosamaria, Cirillo Francesca, Talia Marianna, Scordamaglia Domenica, Gutkind J. Silvio, Maggiolini Marcello, IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells, Cells, 9, 4, 2020. Crossref
-
Özenver Nadire, Efferth Thomas, Small molecule inhibitors and stimulators of inducible nitric oxide synthase in cancer cells from natural origin (phytochemicals, marine compounds, antibiotics), Biochemical Pharmacology, 176, 2020. Crossref
-
Goh Chia Yin, Wyse Cathy, Ho Matthew, O'Beirne Ellen, Howard Jane, Lindsay Sinéad, Kelly Pamela, Higgins Michaela, McCann Amanda, Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?, Cancer Letters, 473, 2020. Crossref
-
Smolková Katarína, Mikó Edit, Kovács Tünde, Leguina-Ruzzi Alberto, Sipos Adrienn, Bai Péter, Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism, Antioxidants & Redox Signaling, 33, 13, 2020. Crossref
-
Khan Faizan H., Dervan Eoin, Bhattacharyya Dibyangana D., McAuliffe Jake D., Miranda Katrina M., Glynn Sharon A., The Role of Nitric Oxide in Cancer: Master Regulator or NOt?, International Journal of Molecular Sciences, 21, 24, 2020. Crossref
-
Abdollahzadeh Foroogh, Nejatollahi Forough, Anti-Proliferative Effect of Specific Anti-EGFR Single Chain Antibody on Triple Negative Breast Cancer Cells, Reports of Biochemistry and Molecular Biology, 9, 2, 2020. Crossref
-
Sári Zsanett, Mikó Edit, Kovács Tünde, Boratkó Anita, Ujlaki Gyula, Jankó Laura, Kiss Borbála, Uray Karen, Bai Péter, Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress, Cancers, 12, 10, 2020. Crossref
-
Ávalos-Moreno Marta, López-Tejada Araceli, Blaya-Cánovas Jose L., Cara-Lupiañez Francisca E., González-González Adrián, Lorente Jose A., Sánchez-Rovira Pedro, Granados-Principal Sergio, Drug Repurposing for Triple-Negative Breast Cancer, Journal of Personalized Medicine, 10, 4, 2020. Crossref
-
Reddy Tejaswini P., Rosato Roberto R., Li Xiaoxian, Moulder Stacy, Piwnica-Worms Helen, Chang Jenny C., A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations, Breast Cancer Research, 22, 1, 2020. Crossref
-
Song Christine, Lowe Val J., Lee SeungBaek, Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC), Breast Cancer, 28, 5, 2021. Crossref
-
Cui Qingbin, Yang Yuqi, Ji Ning, Wang Jing-Quan, Ren Liang, Yang Dong-Hua, Chen Zhe-Sheng, Gaseous signaling molecules and their application in resistant cancer treatment: from invisible to visible, Future Medicinal Chemistry, 11, 4, 2019. Crossref
-
Bouaouiche Sarra, Ghione Silvia, Sghaier Randa, Burgy Olivier, Racoeur Cindy, Derangère Valentin, Bettaieb Ali, Plenchette Stéphanie, Nitric Oxide-Releasing Drug Glyceryl Trinitrate Targets JAK2/STAT3 Signaling, Migration and Invasion of Triple-Negative Breast Cancer Cells, International Journal of Molecular Sciences, 22, 16, 2021. Crossref
-
Alsharabasy Amir M., Glynn Sharon A., Pandit Abhay, The role of extracellular matrix in tumour angiogenesis: the throne has NOx servants, Biochemical Society Transactions, 48, 6, 2020. Crossref
-
Abdelhafez Abeer H., Musall Benjamin C., Adrada Beatriz E., Hess KennethR., Son Jong Bum, Hwang Ken-Pin, Candelaria Rosalind P., Santiago Lumarie, Whitman Gary J., Le-Petross Huong T., Moseley Tanya W., Arribas Elsa, Lane Deanna L., Scoggins Marion E., Leung Jessica W. T., Mahmoud Hagar S., White Jason B., Ravenberg Elizabeth E., Litton Jennifer K., Valero Vicente, Wei Peng, Thompson Alastair M., Moulder Stacy L., Pagel Mark D., Ma Jingfei, Yang Wei T., Rauch Gaiane M., Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC), Breast Cancer Research and Treatment, 185, 1, 2021. Crossref
-
Lin Katie, Baritaki Stavroula, Vivarelli Silvia, Falzone Luca, Scalisi Aurora, Libra Massimo, Bonavida Benjamin, The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis, Antioxidants, 11, 6, 2022. Crossref
-
Pal Ambika, Tapadar Poulami, Pal Ranjana, Exploring the Molecular Mechanism of Cinnamic Acid-Mediated Cytotoxicity in Triple Negative MDA-MB-231 Breast Cancer Cells, Anti-Cancer Agents in Medicinal Chemistry, 21, 9, 2021. Crossref
-
Salihi Abbas, Al‑Naqshabandi Mohammed, Khudhur Zhikal, Housein Zjwan, Hama Harmand, Abdullah Ramyar, Hussen Bashdar, Alkasalias Twana, Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review), Molecular Medicine Reports, 26, 1, 2022. Crossref
-
Aini Shataer, Bolati Shayiti, Ding Wei, Liu Siyin, Su Pengcheng, Aili Saiding, Naman Yimin, Xuekelaiti Kuerban, LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer, Bioengineered, 13, 5, 2022. Crossref
-
Abdel-Latif Mustafa, Riad Ahmed, Soliman Raghda A., Elkhouly Aisha M., Nafae Heba, Gad Mohamed Z., Motaal Amira Abdel, Youness Rana A., MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer, Molecular and Cellular Biochemistry, 477, 4, 2022. Crossref
-
Zhang Lu, Xi Yue, Guo Rui, Miao Ying, Chen Hong, Zhang Min, Li Biao, Bone Marrow Mesenchymal Stem Cell-Mediated Radiosensitive Promoter-Combined Sodium Iodide Symporter for the Treatment of Breast Cancer, Human Gene Therapy, 33, 11-12, 2022. Crossref
-
Chung Andrew W., Anand Kartik, Anselme Ann C., Chan Alfred A., Gupta Nakul, Venta Luz A., Schwartz Mary R., Qian Wei, Xu Yitian, Zhang Licheng, Kuhn John, Patel Tejal, Rodriguez Angel A., Belcheva Anna, Darcourt Jorge, Ensor Joe, Bernicker Eric, Pan Ping-Ying, Chen Shu Hsia, Lee Delphine J., Niravath Polly A., Chang Jenny C., A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer, Science Translational Medicine, 13, 624, 2021. Crossref
-
Burn Olivia K, Farrand Kathryn, Pritchard Tara, Draper Sarah, Tang Ching‐wen, Mooney Anna H, Schmidt Alfonso J, Yang Sung H, Williams Geoffrey M, Brimble Margaret A, Kandasamy Matheswaran, Marshall Andrew J, Clarke Kate, Painter Gavin F, Hermans Ian F, Weinkove Robert, Glycolipid‐peptide conjugate vaccines elicit CD8 + T‐cell responses and prevent breast cancer metastasis , Clinical & Translational Immunology, 11, 7, 2022. Crossref
-
Mou Jiahui, Xu Xiaoding, Wang Feifei, Kong Weiwen, Chen Jing, Ren Jin, HMGN4 plays a key role in STAT3-mediated oncogenesis of triple-negative breast cancer, Carcinogenesis, 2022. Crossref
-
Alsharabasy Amir M., Glynn Sharon, Farràs Pau, Pandit Abhay, Interactions between Nitric Oxide and Hyaluronan Implicate the Migration of Breast Cancer Cells, Biomacromolecules, 23, 9, 2022. Crossref